Innovation. An FDA-cleared over-the-counter glucose monitoring system for weight management

The FDA has cleared, over-the-counter glucose monitoring system designed specifically for weight management.

The new system combines a stelo glucose biosensor with an artificial intelligence-powered platform that provides real-time insights into how food, exercise, stress, and sleep affect the body. Unlike traditional glucose monitors that are primarily used for diabetes care, the system is positioned as a tool for individuals looking to better manage their weight and overall metabolic health.

The device translates glucose fluctuations into personalized recommendations, giving users a clearer picture of how their lifestyle choices affect metabolism.

The system is now available to consumers through their smartphones, giving them what the company calls “real-time metabolic health, made truly accessible.

Traditionally, continuous glucose monitors were developed and prescribed for patients with diabetes, offering clinicians precise, real-time data to manage blood sugar levels. Now, those same technologies are being adapted for general health and weight management, extending their reach to a much larger population.

Recent advances have been driven by the convergence of wearable biosensors, artificial intelligence, and personalized health platforms. Biosensors can now measure glucose levels continuously and with greater accuracy, while AI-driven algorithms translate this complex data into easy-to-understand recommendations. These tools not only track blood sugar fluctuations but also connect them to lifestyle factors such as diet, exercise, sleep, and stress, creating a more holistic view of health.
MB Bureau